Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-28T16:24:58.130Z Has data issue: false hasContentIssue false

Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options

Published online by Cambridge University Press:  15 May 2009

H. R. Babad
Affiliation:
Centre for the Epidemiology of Infectious Disease, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS
D. J. Nokes*
Affiliation:
Centre for the Epidemiology of Infectious Disease, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS
N. J. Gay
Affiliation:
Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ
E. Miller
Affiliation:
Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ
P. Morgan-Capner
Affiliation:
Public Health Laboratory, Royal Preston Hospital, Sharoe Green Lane North, Preston PR2 4HG
R. M. Anderson
Affiliation:
Centre for the Epidemiology of Infectious Disease, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS
*
* Author and address for correspondence.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Measles incidence in England and Wales has fallen to an all-time low. Attention is now focused on preventing local outbreaks, and, in the long run, on the elimination of indigenous measles. A realistic age-structured (RAS) mathematical model of measles transmission is used to reconstruct the impact of measles vaccination in England and Wales from 1968 to the present and to evaluate the merits of future policy options. In general, the predictions of the model show good agreement with long-term age stratified case reports and seroprevalence surveys. The model underestimates the proportion of cases that are notified in 0–2-year-old children. However, recent work suggests a high degree of misdiagnosis in this age group. Projections on the basis of the existing vaccination strategy in the UK suggest that the present level of measles vaccine coverage will be insufficient to eliminate small seasonal outbreaks of measles. This result is, however, sensitive to the assumed level of vaccine efficacy. Explorations of a variety of changes to current vaccination strategy favour a 2-dose schedule with the second dose administered at age 4 years irrespective of vaccination history. A vaccination campaign in school-age children, to reduce deficits in herd immunity, would accelerate progress towards measles elimination.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1995

References

REFERENCES

1.Department of Health. Immunisation against infectious disease. London: HMSO, 1988.Google Scholar
2.Miller, E, Nokes, DJ, Anderson, RM. Measles, mumps and rubella vaccination. BMJ 1992; 304: 1440–1.CrossRefGoogle ScholarPubMed
3.Office of Population Censuses and Surveys. Statistics of infectious diseases. London: HMSO, 19741993.Google Scholar
4.Carter, H.Gorman, D. Measles, mumps, and rubella vaccine: time for a two stage policy? BMJ 1992; 304: 779.CrossRefGoogle ScholarPubMed
5.Registrar General's Statistical Review. Annual review of the Registrar General of England and Wales. London: HMSO, 19481973.Google Scholar
6.Nokes, DJ.Anderson, RM. The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes. Epidemiol Infect 1988: 101: 120.CrossRefGoogle ScholarPubMed
7.Hamer, W. Epidemic disease in England. Lancet 1906; i: 733–9.Google Scholar
8.Fine, PEM, Clarkson, JA. Measles in England and Wales. I. An analysis of factors underlying seasonal patterns. Int J Epidemiol 1982; 11: 514.Google Scholar
9.Schenzle, D. An age-structured model of pre- and post-vaccination measles transmission. IMAJ Math Appl Med Biol 1984; 1: 169–91.CrossRefGoogle ScholarPubMed
10.Anderson, RM, May, RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hygiene 1985; 94: 365436.CrossRefGoogle ScholarPubMed
11.Bolker, BM, Grenfell, BT. Chaos and biological complexity in measles dynamics. Philosoph Trans R Soc Lond B Biol Sciences 1993; 251: 7581.Google ScholarPubMed
12.Anderson, RM, Nokes, DJ. Mathematical models of transmission and control. In: Holland, WW, Detels, T, Knox, G, eds. Oxford textbook of public health. Oxford: Oxford Medical Publications, 1991.Google Scholar
13.Ukkonen, P, Von Bonsdorf, C-H. Rubella immunity and morbidity: effects of vaccination in Finland. Scand J Infect Dis 1988; 20: 255–9.CrossRefGoogle ScholarPubMed
14.Grenfell, BT, Anderson, RM. The estimation of age-related rates of infection from case notifications and serological data. J Hygiene 1985; 95: 419–36.Google Scholar
15.Brown, D, Ramsay, M, Richards, A, Miller, E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1992–93. BMJ 1994; 308: 1015–17.CrossRefGoogle Scholar
16.Morgan-Capner, P, Wright, J, Miller, CEM. Surveillance of measles, mumps and rubella by age. BMJ 1988: 297: 770–2.CrossRefGoogle ScholarPubMed
17.Farrington, CP. Modelling forces of infection for measles, mumps and rubella. Stat Med 1990; 9: 953–67.CrossRefGoogle ScholarPubMed
18.Anderson, RM.Grenfell, BT. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom. J Hyg 1986; 96: 305–33.CrossRefGoogle ScholarPubMed
19.Anderson, RM, May, RM. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg 1983; 90: 259325.Google Scholar
20.Anderson, RM, May, RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press, 1991.CrossRefGoogle Scholar
21.Department of Education and Science. Statistical Bulletin. Government Statistical Service. 19821991.Google Scholar
22.Department for Education. Statistical Bulletin. Government Statistical Service, 1992.Google Scholar
23.Department of Health Statistics Division. Vaccination and immunisation, England. Government Statistical Service, 19681993.Google Scholar
24.Office of Population Censuses and Surveys. Birth Statistics, 19681993. OPCS No. 13 and 20. London: HMSO.Google Scholar
25.Fine, PEM, Zell, ER. Outbreaks in highly vaccinated populations – implications for studies of vaccine performance. Amer J Epidemiol 1994; 139: 7790.CrossRefGoogle ScholarPubMed
26.Morse, D, O'Shea, M, Hamilton, G et al. , Outbreak of measles in a teenage school population: the need to immunize susceptible adolescents. Epidemiol Infect 1994; 113: 355–65.Google Scholar
27.Calvert, N, Cutts, F, Miller, E, Brown, D, Munro, J. Measles among secondary school children in west Cumbria: implications for vaccine policy. CDR Review 1994; 4: R706.Google Scholar
28.Walker, J, Nokes, DJ, Jennings, R. Longitudinal study of toxoplasma in South Yorkshire. Epidemiol Infect 1992; 108: 99106.CrossRefGoogle ScholarPubMed
29.Cox, MJ. Seroepidemiology of measles, mumps and rubella in St. Lucia and Jamaica [thesis]. London: London University, 1989.Google Scholar
30.Begg, N, White, J, Handford, S. “COVER” (Cover of vaccination evaluated rapidly) 13. Commun Dis Rep 1990; 90(13): 34.Google Scholar
31.Department of Health. Immunisation against infectious disease. London: HMSO. 1993.Google Scholar
32.Agur, Z, Cojocaru, L, Mazor, G, Anderson, RM, Danon, YL. Pulse mass measles vaccination across age cohorts. Proc Nat Acad Sci USA 1993; 90: 11698–702.CrossRefGoogle ScholarPubMed
33.Bailey, NJT. On estimating the latent and infectious periods of measles. 1. Families with two susceptibles only. Biometrika 1956; 43: 15.CrossRefGoogle Scholar
34.Bailey, NJT. The mathematical theory of infectious diseases. London: Griffin, 1975.Google Scholar
35.Nokes, DJ.Wright, J, Morgan-Capner, P, Anderson, RM. Serological study of the epidemiology of mumps virus infection in North-West England. Epidemiol Infect 1990: 105: 175–95.CrossRefGoogle ScholarPubMed